Plan robustness in proton beam therapy of a childhood brain tumour

References

• Athar PS, Paganetti H. Comparison of second cancer risk due to out-of-field doses from 6 MV IMRT and proton therapy based on 6 pediatric treatment plans. Radiother Oncol 2011;98:87–92.
   PubMed Web of Science ®Google Scholar
• Lomax AJ, Bortfeld T, Goitein G, Debus J, Tercier PA, Coucke PA, . A treatment planning inter-comparison of protons and intensity modulated photon therapy. Radiother Oncol 1999;51:257–71.
   PubMed Web of Science ®Google Scholar
• Chen L, Mao Y, Chen H, Zhou LF. Diagnosis and management of intracranial malignant peripheral nerve sheath tumors. Neurosurgery 2008;62:825–32.
   PubMed Web of Science ®Google Scholar
• Zhang P, Happersett L, Hunt M, Jackson A, Zelefsky M, Mageras G. Volumetric modulated arc therapy: Planning and evaluation for prostate cancer cases. Int J Radiat Oncol Biol Phys 2010;76:1456–62.
   PubMed Web of Science ®Google Scholar
• Shaffer R, Nichol AM, Vollans E, Fong M, Nakano S, Moiseenko V, . A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas. Int J Radiat Oncol Biol Phys 2010;76:1177–84.
   PubMed Web of Science ®Google Scholar
• Wagner D, Christiansen H, Wolff H, Vorwerk H. Radiotherapy of malignant gliomas: Comparison of volumetric single arc (RapidArc), dynamic intensity-modulated technique and 3 D conformal technique. Radiother Oncol 2009;93:593–6.
   PubMed Web of Science ®Google Scholar
• Lomax AJ. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 1: The potential effects of calculational uncertainties. Phys Med Biol 2008;53:1027–42.
   PubMed Web of Science ®Google Scholar
• Lomax AJ. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: The potential effects of inter-fraction and inter-field motions. Phys Med Biol 2008; 53:1043–56.
   PubMed Web of Science ®Google Scholar
• Albertini F, Bolsi A, Lomax AJ, Rutz HP, Timmermann B, Goitin G, . Sensitivity of intensity modulated proton therapy plans to changes in patient weight. Radiother Oncol 2008;86:187–94.
   PubMed Web of Science ®Google Scholar
• Soukup M, Söhn M, Yan D, Liang J, Alber M. Study of robustness of IMPT and IMRT for prostate cancer against organ movement. Int J Radiat Oncol Biol Phys 2009;75:941–9.
   PubMed Web of Science ®Google Scholar
• Unkelbach J, Bortfeld T, Martin BC, Soukup M. Reducing the sensitivity of IMPT treatment plans to setup errors and range uncertainties via probabilistic treatment planning. Med Phys 2009;36:149–63.
   PubMed Web of Science ®Google Scholar
• Pflugfelder D, Wilkens JJ, Oelfke U. Worst case optimization: A method to account for uncertainties in the optimization of intensity modulated proton therapy. Phys Med Biol 2008;53:1689–700.
   PubMed Web of Science ®Google Scholar
• Albertini F, Hug EB, Lomax AJ. The influence of the optimization starting conditions on the robustness of intensity-modulated proton therapy plans. Phys Med Biol 2010;55: 2863–78.
   PubMed Web of Science ®Google Scholar
• Hui Z, Zhang X, Starkschall G, Li Y, Mohan R, Komaki R, . Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer. Int J Radiat Oncol Biol Phys 2008;72:1385–95.
   PubMed Web of Science ®Google Scholar
• Knap MM, Hoffmann L, Nordsmark M, Vestergaard A. Daily cone-beam computed tomography used to determine tumor shrinkage and localisation in lung cancer patients. Acta Oncol 2010;49:1077–84.
   PubMed Web of Science ®Google Scholar
• Vestergaard A, Søndergaard J, Petersen JB, Høyer M, Muren LP. A comparison of three different adaptive strategies in image-guided radiotherapy of bladder cancer. Acta Oncol 2010;49:1069–76.
   PubMed Web of Science ®Google Scholar
• Kron T, Wong J, Rolfo A, Pham D, Cramb J, Foroudi F. Adaptive radiotherapy for bladder cancer reduces integral dose despite daily volumetric imaging. Radiother Oncol 2010;97:485–7.
   PubMed Web of Science ®Google Scholar
• Lütgendorf-Caucig C, Fotina I, Stock M, Pötter R, Goldner G, Georg D. Feasibility of CBCT-based target and normal structure delineation in prostate cancer radiotherapy: Multi-observer and image multi-modality study. Radiother Oncol 2011;98:154–61.
   PubMed Web of Science ®Google Scholar
• Elstrøm UV, Wysocka BA, Muren LP, Petersen JB, Grau C. Daily kv cone-beam CT and deformable image registration as a method of studying dosimetric consequences of anatomic changes in adaptive IMRT of head and neck cancer. Acta Oncol 2010;49:1101–8.
   PubMed Web of Science ®Google Scholar
• Søvik Å, Rødal J, Skogmo HK, Lervåg C, Eilertsen K, Malinen E. Adaptive radiotherapy based on contrast enhanced cone beam CT imaging. Acta Oncol 2010;49:972–7.
   PubMed Web of Science ®Google Scholar
• Buhl SK, Duun-Kristensen AK, Christensen BH, Behrens CF. Clinical evaluation of 3D/3D MRI-CBCT automatching on brain tumors for online patient setup verification – A step toward MRI-based treatment planning. Acta Oncol 2010; 49:1085–91.
   PubMed Web of Science ®Google Scholar
• Raaymakers BW, Lagendijk JJ, Overweg J, Kok JG, Raaijmakers AJ, Kerkhof EM, . Integrating a 1.5 T MRI scanner with a 6 MV accelerator: Proof of concept. Phys Med Biol 2009;54:N229–37.
   PubMed Web of Science ®Google Scholar
• Raaymakers BW, Raaijemakers AJE, Lagendijk JJW. Feasibility of MRI guided proton therapy: Magnetic field dose effects. Phys Med Biol 2008;53:5615–22.
   PubMed Web of Science ®Google Scholar